Antithrombotic Treatment and Its Association with Outcome in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients
Transcatheter edge-to-edge mitral valve repair (TEER) has become established as a safe and efficacious therapy for severe mitral regurgitation (MR) in high-risk patients. Despite its widespread use, postprocedural antithrombotic therapy (ATT) still to date is based on local expertise rather than evi...
Saved in:
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Philipps-Universität Marburg
2022
|
Subjects: | |
Online Access: | PDF Full Text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
PDF Full TextCall Number: |
urn:nbn:de:hebis:04-es2023-01363 |
---|---|
Publication Date: |
2023-09-04 |
Source: |
Erstveröffentlichung: Waechter, C.; Ausbuettel, F.; Chatzis, G.; Cheko, J.; Fischer, D.; Nef, H.; Barth, S.; Halbfass, P.; Deneke, T.; Mueller, J.; et al. Antithrombotic Treatment and Its Association with Outcome in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients. J. Cardiovasc. Dev. Dis. 2022, 9, 366. https://doi.org/10.3390/jcdd9110366 |
Downloads: |
71 (2024), 26 (2023) |
License: |
https://creativecommons.org/licenses/by/4.0 |
Access URL: |
https://archiv.ub.uni-marburg.de/es/2023/0136 https://doi.org/10.3390/jcdd9110366 |